Brunei vs Sweden: Cause of death, by non-communicable diseases, ages 5-14, male
Brunei
74.9%
in 2021
Sweden
77.7%
in 2021
Brunei rank
5th
Sweden rank
2nd
Cause of death, by non-communicable diseases, ages 5-14, male over time
- Brunei
- Sweden
How they compare
Sweden currently reports 77.7% against 74.9% in Brunei, a difference of 2.8%.
The two have swapped places 4 times across 6 shared years of data; in 2000 it was Sweden ahead.
Brunei ranks 5th and Sweden ranks 2nd of 185 countries.
Across the 3 decades both report, Brunei averaged higher in 2 and Sweden in 1.
Head to head by decade
| Decade | Brunei | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.1% | 61.8% | 37.8% | Sweden |
| 2010s | 65.5% | 61.7% | 3.7% | Brunei |
| 2020s | 74.5% | 66.5% | 8.0% | Brunei |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, male, Brunei or Sweden?
- Sweden, at 77.7% against 74.9% in Brunei as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14, male between Brunei and Sweden?
- 2.8%, with Sweden ahead.
- How many years of comparable data are there for Brunei and Sweden?
- 6 years are reported by both, from 2000 to 2021.
- How do Brunei and Sweden rank globally for cause of death, by non-communicable diseases, ages 5-14, male?
- Brunei ranks 5th and Sweden ranks 2nd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14, male (% of total male deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 5-14 due to non-communicable diseases divided by number of all male deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.